A647D decreased mexiletine sensitivity of P1332L when coexpressed. by Jie Liu (15128)

Co-expression of WT with M195T–WT decreases the stability of heteromers. by Cinzia Ambrosi (446348)

A647D mutation decreases I_Na of WT and P1332L when co-expressed. by Jie Liu (15128)

Δ3C virus-induced lymphomas have decreased expression of E2F target genes. by James C. Romero-Masters (4112614)

Overexpression of PR decreases Myc expression and activity. by Tamar Kavlashvili (849072)

Metformin decreases CRC-like organoids viability to the same extent as current chemotherapy without significant effects on WT organoids. by Silvia Cruz-Gil (7037249)

MMR mutants show decreased mating-type silencing. by Qian Liu (135614)

“…The plasmids (<i>pRS425</i> and <i>pRS425-Gal10-MSH2</i>) were transformed to <i>msh2</i>Δ mutants in both WT (<i>his3Δ</i>) and UCC3505 backgrounds. Cells were five-fold serially diluted and then spotted onto SD-ura-leu + 2% glucose (left) or SD-ura-leu + 2% galactose (right) agar plates. …”

– Decreasing rank differences in the comparison Wt-t0b vs Wt-t0a are plotted (in blue) against the rank of Wt-t0a and decreasing rank differences in the comparison Wt-t0a vs Wt-t0b... by Dietmar E Martin (5143)

Injection of pNaKtide diminishes PNx-induced decrease in miR-29b-3p expression. by Christopher A. Drummond (3845110)

The rate of lariat formation is decreased two-fold by isoginkgetin treatment. by Jesse M. Gray (527662)

“…<p>(<b>A</b>) Genome-wide expression of 5′ splice sites, 3′ splice sites, and introns are increased relative to exons upon treatment of HeLa cells with isoginkgetin (30 µM, 18 hours), based on total RNA-Seq (dUTP method <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0089673#pone.0089673-Parkhomchuk1" target="_blank">[18]</a>, Illumina). …”

MEK5 expression decreases ER signaling and confers endocrine resistance. by James W. Antoon (444010)

Decreased expression of HATL5 mRNA and protein in human carcinomas. by Gregory S. Miller (519005)

Mutation of four arginine residues in P34 leads to a decrease in binding between P34 and L5. by Anyango D. Kamina (4034165)

RMSD graphs for the backbone of WT PARG1, I845V and T622M mutants. by Zen Kouchi (14898435)

mTOR activity is decreased in KSR1-deficient T cells. by Marie Le Borgne (337225)

phosphoATM focal intensity decreases at DSBs undergoing resection. by Verena Geuting (440327)

5-fold cross-validation comparison results. by Chunming Wen (17616274)

Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

“…Specifically, compound <b>20g</b> displayed a 3.67-fold decrease of plasma AUC_{(tofacitinib, 0–∞)} and a 9.61-fold increase of colonic AUC_{(tofacitinib, 0–12h)}, compared with tofacitinib at a molar equivalent oral dose. …”

Deficiency in ArgEF or CpcA but not ArgB decreases the cellular ornithine content. by Nicola Beckmann (194193)

Intracellular levels of HSPG core proteins, HS and HPSE are decreased in ER stressed MIN6 cells. by Sarita Dhounchak (10924448)